Literature DB >> 7508805

Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research.

N Rotman1, D Pezet, P L Fagniez, D Cherqui, B Celicout, P Lointier.   

Abstract

The records of 66 patients with histologically proven adenocarcinoma of the duodenum were reviewed retrospectively to determine factors influencing survival. The parameters studied were age, sex, weight loss, jaundice, anaemia, duodenal stenosis, type of surgical procedure, tumour size and location, depth of parietal invasion, presence and location of lymph node metastases, and pancreatic invasion. These factors were assessed in a group of 46 patients who underwent curative resection of the tumour; 20 patients who received palliative procedures were excluded from statistical analysis. Survival curves were established by the Kaplan-Meier method and compared by the Mantel-Haentszel test. The actuarial 3- and 5-year survival rates of patients undergoing curative resection were 59 and 45 per cent respectively. None of the prognostic factors studied influenced survival. These results indicate that resection of adenocarcinoma of the duodenum should be performed whenever possible, even in the presence of lymph node metastasis and pancreatic spread.

Entities:  

Mesh:

Year:  1994        PMID: 7508805     DOI: 10.1002/bjs.1800810128

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.

Authors:  George A Poultsides; Lyen C Huang; John L Cameron; Richard Tuli; Leslie Lan; Ralph H Hruban; Timothy M Pawlik; Joseph M Herman; Barish H Edil; Nita Ahuja; Michael A Choti; Christopher L Wolfgang; Richard D Schulick
Journal:  Ann Surg Oncol       Date:  2011-12-14       Impact factor: 5.344

Review 2.  Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.

Authors:  Pipit Burasakarn; Ryota Higuchi; Souya Nunobe; Shingo Kanaji; Hidetoshi Eguchi; Ken-Ichi Okada; Tsutomu Fujii; Yuichi Nagakawa; Kengo Kanetaka; Hiroharu Yamashita; Suguru Yamada; Shinji Kuroda; Toru Aoyama; Takahiro Akahori; Kenji Nakagawa; Masakazu Yamamoto; Hiroki Yamaue; Masayuki Sho; Yasuhiro Kodera
Journal:  Int J Clin Oncol       Date:  2021-01-01       Impact factor: 3.402

3.  Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China.

Authors:  Shenghong Zhang; Yi Cui; Bihui Zhong; Weiwei Xiao; Xiaorong Gong; Kang Chao; Minhu Chen
Journal:  Int J Colorectal Dis       Date:  2010-10-08       Impact factor: 2.571

4.  Primary duodenal carcinoma.

Authors:  O A Adedeji; C Trescoli-Serrano; M Garcia-Zarco
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

5.  Prognostic factors for primary duodenal adenocarcinoma.

Authors:  Hyung Geun Lee; Dong Do You; Kwang Yeol Paik; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

6.  Primary adenocarcinoma of the fourth portion of the duodenum: "A case report and literature review".

Authors:  Toru Nakano; Koh Sugawara; Kenji Hirau; Yutaka Hirano; Masaji Hashimoto; Tsuneo Kaiho; Noriaki Ohuchi
Journal:  Int J Surg Case Rep       Date:  2013-04-19

Review 7.  Duodenal adenocarcinoma: Advances in diagnosis and surgical management.

Authors:  Jordan M Cloyd; Elizabeth George; Brendan C Visser
Journal:  World J Gastrointest Surg       Date:  2016-03-27

8.  Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.

Authors:  Maryam Zenali; Michael J Overman; Asif Rashid; Russell B Broaddus; Hua Wang; Matthew H Katz; Jason B Fleming; James L Abbruzzese; Huamin Wang
Journal:  Hum Pathol       Date:  2013-10-15       Impact factor: 3.466

9.  Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma.

Authors:  Woo Chul Chung; Chang Nyol Paik; Sung Hoon Jung; Kang-Moon Lee; Sang Woo Kim; U-Im Chang; Jin Mo Yang
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

10.  The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil.

Authors:  C Crawley; P Ross; A Norman; A Hill; D Cunningham
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.